PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MED vs. VFC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MED and VFC is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

MED vs. VFC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and V.F. Corporation (VFC). The values are adjusted to include any dividend payments, if applicable.

200.00%400.00%600.00%800.00%1,000.00%NovemberDecember2025FebruaryMarchApril
235.89%
384.39%
MED
VFC

Key characteristics

Sharpe Ratio

MED:

-1.22

VFC:

-0.24

Sortino Ratio

MED:

-2.02

VFC:

0.09

Omega Ratio

MED:

0.75

VFC:

1.01

Calmar Ratio

MED:

-0.64

VFC:

-0.18

Martin Ratio

MED:

-1.31

VFC:

-1.11

Ulcer Index

MED:

46.64%

VFC:

13.70%

Daily Std Dev

MED:

50.21%

VFC:

63.10%

Max Drawdown

MED:

-98.33%

VFC:

-86.24%

Current Drawdown

MED:

-95.52%

VFC:

-86.24%

Fundamentals

Market Cap

MED:

$144.27M

VFC:

$4.50B

EPS

MED:

$0.19

VFC:

-$0.37

PEG Ratio

MED:

1.95

VFC:

0.14

Total Revenue (TTM)

MED:

$427.72M

VFC:

$7.50B

Gross Profit (TTM)

MED:

$317.33M

VFC:

$4.04B

EBITDA (TTM)

MED:

$1.20M

VFC:

$466.30M

Returns By Period

In the year-to-date period, MED achieves a -25.14% return, which is significantly higher than VFC's -45.88% return. Over the past 10 years, MED has outperformed VFC with an annualized return of -5.27%, while VFC has yielded a comparatively lower -14.18% annualized return.


MED

YTD

-25.14%

1M

-6.39%

6M

-28.47%

1Y

-61.07%

5Y*

-23.23%

10Y*

-5.27%

VFC

YTD

-45.88%

1M

-50.47%

6M

-45.27%

1Y

-14.66%

5Y*

-22.51%

10Y*

-14.18%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MED vs. VFC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
The Risk-Adjusted Performance Rank of MED is 99
Overall Rank
The Sharpe Ratio Rank of MED is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of MED is 33
Sortino Ratio Rank
The Omega Ratio Rank of MED is 55
Omega Ratio Rank
The Calmar Ratio Rank of MED is 1515
Calmar Ratio Rank
The Martin Ratio Rank of MED is 2020
Martin Ratio Rank

VFC
The Risk-Adjusted Performance Rank of VFC is 4040
Overall Rank
The Sharpe Ratio Rank of VFC is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of VFC is 4343
Sortino Ratio Rank
The Omega Ratio Rank of VFC is 4444
Omega Ratio Rank
The Calmar Ratio Rank of VFC is 4545
Calmar Ratio Rank
The Martin Ratio Rank of VFC is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MED vs. VFC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and V.F. Corporation (VFC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MED, currently valued at -1.22, compared to the broader market-2.00-1.000.001.002.00
MED: -1.22
VFC: -0.24
The chart of Sortino ratio for MED, currently valued at -2.02, compared to the broader market-6.00-4.00-2.000.002.004.00
MED: -2.02
VFC: 0.09
The chart of Omega ratio for MED, currently valued at 0.75, compared to the broader market0.501.001.502.00
MED: 0.75
VFC: 1.01
The chart of Calmar ratio for MED, currently valued at -0.64, compared to the broader market0.001.002.003.004.00
MED: -0.64
VFC: -0.18
The chart of Martin ratio for MED, currently valued at -1.31, compared to the broader market-10.000.0010.0020.00
MED: -1.31
VFC: -1.11

The current MED Sharpe Ratio is -1.22, which is lower than the VFC Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of MED and VFC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-1.22
-0.24
MED
VFC

Dividends

MED vs. VFC - Dividend Comparison

MED has not paid dividends to shareholders, while VFC's dividend yield for the trailing twelve months is around 3.11%.


TTM20242023202220212020201920182017201620152014
MED
Medifast, Inc.
0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%0.00%
VFC
V.F. Corporation
3.11%1.68%5.27%7.28%2.69%2.26%1.91%2.65%2.33%2.87%2.14%1.48%

Drawdowns

MED vs. VFC - Drawdown Comparison

The maximum MED drawdown since its inception was -98.33%, which is greater than VFC's maximum drawdown of -86.24%. Use the drawdown chart below to compare losses from any high point for MED and VFC. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%NovemberDecember2025FebruaryMarchApril
-95.52%
-86.24%
MED
VFC

Volatility

MED vs. VFC - Volatility Comparison

The current volatility for Medifast, Inc. (MED) is 12.73%, while V.F. Corporation (VFC) has a volatility of 36.10%. This indicates that MED experiences smaller price fluctuations and is considered to be less risky than VFC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%NovemberDecember2025FebruaryMarchApril
12.73%
36.10%
MED
VFC

Financials

MED vs. VFC - Financials Comparison

This section allows you to compare key financial metrics between Medifast, Inc. and V.F. Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab